Results 161 to 170 of about 36,038 (221)

6. Forschungswerkstatt Moxifloxacin 01. - 02. März 2007 ; [extended meeting abstracts]

, 2007
Forschungswerkstatt Moxifloxacin 2007 Leverkusen
core  

Genetic surveillance of first- and second-line drug-resistant isolates of Mycobacterium tuberculosis in Peru. [PDF]

PLoS One
Santos-Lázaro D, Vigo AN, Cotrina VV, Villar S, Medina A, Julcapoma C, Pacheco E, Alarcón MJ, Puyén ZM.   +8 more
europepmc   +1 more source

Beta-Lactam Plus Azithromycin or Doxycycline vs Fluoroquinolones in Adult Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Network Meta-analysis. [PDF]

Open Forum Infect Dis
Farah MH, Abusalih M, Farah W, El Labban M, Haydour Q, Ramachandran N, Wang Z, Barreto EF, Prokop L, Murad MH, Odeyemi Y.   +10 more
europepmc   +1 more source

Cost-effectiveness of BPaL-based and 9-month modified all-oral short treatment regimens for rifampicin-resistant tuberculosis in Belarus. [PDF]

PLOS Glob Public Health
Yatskevich N.
europepmc   +1 more source

Comparison of preoperative 5% povidone-iodine plus moxifloxacin versus 5% povidone-iodine alone on ocular surface bacterial flora: protocol for a randomized controlled trial. [PDF]

BMC Ophthalmol
Ugalahi MO, Makanjuola OB, Adebusoye SO, Olusanya BA.   +3 more
europepmc   +1 more source

Fluoroquinolones as the linchpin of tuberculosis therapy: contrasting efficacy and resistance profiles in <i>Mycobacterium tuberculosis</i> versus <i>Mycobacterium abscessus</i>. [PDF]

Front Cell Infect Microbiol
Kuzioła M, Korycka-Machała M, Zygała-Pytlos D, Dziadek B, Kawka M, Pawełczyk J, Odolczyk N, Zielenkiewicz P, Słomka M, Dziadek J.   +9 more
europepmc   +1 more source

Trends and Characteristics of Drug-Resistant Tuberculosis: A Five-Year Study at a Major Specialized Hospital in Guizhou, China (2018-2023). [PDF]

Infect Drug Resist
Huang J, Cao X, Wang M, Du L, Chen X, Tu Y, Feng Y.   +6 more
europepmc   +1 more source

Analysis of the impact of national centralized volume-based procurement drug policy on the market dynamics of tuberculosis drugs. [PDF]

BMC Health Serv Res
Yang J, Yu X, Yao Y, Zhao W, Chen Y, Wang Z, Xu M.   +6 more
europepmc   +1 more source

Drug resistance of <i>Mycoplasma genitalium</i>: mechanism and regional distribution. [PDF]

Front Cell Infect Microbiol
Ouyang Y, Zhang Y, Long Z, Wu X, Li N, Liu X, Lin J, Niu Y, Chen J, Tang J, Xiao C, Liu P, Zhang Y, Gong W.   +13 more
europepmc   +1 more source

Development and validation of HPLC-FLD method for simultaneous determination of ternary therapy used for COVID-19 in plasma samples. [PDF]

Sci Rep
Madbouly EA, El-Shanawani AA, El-Adl SM, Abdelkhalek AS.   +3 more
europepmc   +1 more source